by Scott Larrivee | Aug 7, 2025 | News
The Honorable Dr. David J. Shulkin, Corey Johnston and Seema Singh Bhan Appointed as Initial Advisory Board Members WEST VALLEY CITY, Utah – Aug. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the formation of a...
by Scott Larrivee | Jul 9, 2025 | News
Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run Power and efficiency of Nusano system to surpass existing commercial methodologies Beam time reservations and isotope supply agreements underway WEST...
by Scott Larrivee | Jun 26, 2025 | Podcast
In this episode of Talk Radioisotopes, host Scott Larrivee and guest Paul Schrimpf, Proprietor and Entrepreneur at Cyrall, unpacks what it takes to build and scale a radiopharmaceutical business. With a background spanning Accenture, Prophet, and leadership roles...
by Scott Larrivee | Jun 26, 2025 | News
The following is a copy of a press release issued by Cellectar Biosciences Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for...
by Scott Larrivee | Jun 26, 2025 | Blog
Nusano’s CEO, Chris Lowe, recently spoke to Ravi Kumar for the Connor Group’s Breakthrough Work podcast. The discussion covered: How Chris went from being CFO to leading Nusano as their CEO How Nusano technology is changing pharma, energy, and other...
